Mekanistic Therapeutics is a drug designer for cancer.
Mekanistic Therapeutics has raised $30.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2022.
Mekanistic Therapeutics is headquartered in Ann Arbor, United States.
Mekanistic Therapeutics is a drug designer for cancer.
Mekanistic Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mekanistic Therapeutics — Funding & Investors." VCBacked, June 2, 2022, https://www.vcbacked.co/company/mekanistic-therapeutics. Accessed August 13, 2026.
VCBacked. (2022). Mekanistic Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/mekanistic-therapeutics
{{cite web |title=Mekanistic Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mekanistic-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated